Shares of Artelo Biosciences edged up after the company said preclinical data for its ART12.11 drug candidate showed cognitive benefits over existing antidepressants. The stock rose 63% to $16.35 ...

In a 28-day treatment regimen, ART12.11 significantly reversed behavioral impairments in male rats exposed to chronic stress. The compound improved sucrose preference and social motivation, ...

Data Being Presented at the 35th Annual International Cannabinoid Research Society Symposium SOLANA BEACH, Calif., July 07, ...